Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurotoxicity Syndromes | 2 | 2025 | 51 | 0.430 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2025 | 791 | 0.420 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2025 | 172 | 0.410 |
Why?
|
| Methotrexate | 2 | 2025 | 317 | 0.390 |
Why?
|
| Induction Chemotherapy | 1 | 2025 | 54 | 0.230 |
Why?
|
| Pharmacogenomic Variants | 1 | 2024 | 37 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2025 | 134 | 0.210 |
Why?
|
| Survivorship | 1 | 2023 | 46 | 0.200 |
Why?
|
| Metabolome | 1 | 2025 | 317 | 0.200 |
Why?
|
| Metabolomics | 1 | 2025 | 459 | 0.180 |
Why?
|
| Patient Preference | 1 | 2023 | 140 | 0.180 |
Why?
|
| Cancer Survivors | 1 | 2023 | 258 | 0.160 |
Why?
|
| Caregivers | 1 | 2023 | 563 | 0.140 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 27 | 0.110 |
Why?
|
| Anemia, Sideroblastic | 1 | 2014 | 15 | 0.110 |
Why?
|
| Mitochondrial Myopathies | 1 | 2014 | 28 | 0.110 |
Why?
|
| Acidosis, Lactic | 1 | 2014 | 30 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 234 | 0.100 |
Why?
|
| Young Adult | 4 | 2025 | 9714 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2853 | 0.070 |
Why?
|
| Adolescent | 5 | 2025 | 20183 | 0.060 |
Why?
|
| Child | 5 | 2025 | 25362 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2025 | 14522 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2024 | 197 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2004 | 215 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 144 | 0.050 |
Why?
|
| Male | 7 | 2025 | 62935 | 0.050 |
Why?
|
| Machine Learning | 1 | 2025 | 327 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 788 | 0.040 |
Why?
|
| Glioma | 1 | 2004 | 480 | 0.040 |
Why?
|
| Female | 6 | 2025 | 68803 | 0.040 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1999 | 62 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 252 | 0.030 |
Why?
|
| Parents | 1 | 2023 | 1078 | 0.030 |
Why?
|
| Lymphoma | 1 | 1999 | 320 | 0.030 |
Why?
|
| Humans | 7 | 2025 | 127585 | 0.030 |
Why?
|
| Texas | 1 | 2023 | 3566 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 1236 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2014 | 24 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3932 | 0.030 |
Why?
|
| Point Mutation | 1 | 2014 | 335 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 788 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 809 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 12850 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 2544 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3592 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2921 | 0.020 |
Why?
|
| Middle Aged | 2 | 2023 | 27867 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17105 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 30609 | 0.020 |
Why?
|
| Oligodendroglioma | 1 | 2004 | 20 | 0.010 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2004 | 25 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 138 | 0.010 |
Why?
|
| Astrocytoma | 1 | 2004 | 96 | 0.010 |
Why?
|
| Ependymoma | 1 | 2004 | 141 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 690 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 1487 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 1370 | 0.010 |
Why?
|
| Bone Marrow Examination | 1 | 1999 | 14 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 1791 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1999 | 81 | 0.010 |
Why?
|
| Karyotyping | 1 | 1999 | 314 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 449 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 360 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 2604 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 760 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 337 | 0.010 |
Why?
|
| Biopsy | 1 | 1999 | 1234 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 6172 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 12596 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 7427 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1999 | 8389 | 0.000 |
Why?
|